Liao, Chunyu
Ttofali, Fani
Slotkowski, Rebecca A.
Denny, Steven R.
Cecil, Taylor D.
Leenay, Ryan T.
Keung, Albert J.
Beisel, Chase L. http://orcid.org/0000-0003-0650-9943
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1R35GM119561, 1DP1DA044359)
Camille and Henry Dreyfus Foundation (2017-137)
Agilent Technologies (Gift #3926)
Article History
Received: 30 October 2018
Accepted: 22 May 2019
First Online: 3 July 2019
Competing interests
: C.L.B. is a co-founder and scientific advisory board member of Locus Biosciences and has submitted provisional patent applications on CRISPR technologies. The other authors declare no competing interests.